Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 23, 2015 10:34 AM ET

Biotechnology

Company Overview of KaloBios Pharmaceuticals, Inc.

Key Executives for KaloBios Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Herbert C. Cross No RelationshipsInterim Chief Executive Officer and Chief Financial Officer42
Charles J. Democko No RelationshipsSenior Vice President of Regulatory Affairs and Quality59
Anne Borgman Hagey M.D.No RelationshipsAssociate Chief Medical Officer46
Dan Shochat Ph.D.35 RelationshipsHead of Non-Clinical Development and Vice President74
Carol Stratford Ph.D., J.D.No RelationshipsHead of Intellectual Property and General Counsel--

KaloBios Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Ted W. Love M.D. 104 RelationshipsGlobal Blood Therapeutics, Inc.55
James W. Larrick Ph.D. 41 RelationshipsKaloBios Pharmaceuticals, Inc.--
Raymond M. Withy Ph.D. 7 RelationshipsKaloBios Pharmaceuticals, Inc.59
Denise M. Gilbert Ph.D. 7 RelationshipsKaloBios Pharmaceuticals, Inc.56
Gary A. Lyons 36 RelationshipsRigel Pharmaceuticals, Inc.63
View All Board Members

KaloBios Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Ph.D.Denise M. Gilbert7 Relationships2 Executives
Compensation Committee Gary A. Lyons36 Relationships3 Executives
Nominating Committee Ph.D.Raymond M. Withy7 Relationships2 Executives
Corporate Governance Committee Ph.D.Raymond M. Withy7 Relationships2 Executives
Advisory Board Ph.D.James W. Larrick41 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
378.5K
Bonus
226.9K
Total Short Term Compensation
464.7K
Total Value of Options
30.8M
Compensation as of Fiscal Year
KaloBios Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

The Clorox Company Announces Board Changes
May 15, 2015 12:46 PM ET
Ryan Announces Executive Changes
May 13, 2015 4:55 PM ET
Church & Dwight Co. Inc. Announces Executive Changes
May 07, 2015 10:45 AM ET
Monica Nassif Joins Aunt Fannie's Board of Directors
May 05, 2015 1:32 PM ET
SCA Announces Resignation of Rolf Börjesson as Member of the Board of Directors
May 04, 2015 5:57 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KaloBios Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.